Cargando…

Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection

BACKGROUND: Hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) remains a serious problem in the clinical management of post-oLT patients. Recently, two case reports have described successful prevention of HCV liver graft reinfection with intravenous silibinin (SIL) monot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aghemo, Alessio, Bhoori, Sherrie, De nicola, Stella, Mazzaferro, Vincenzo, Colombo, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412559/ https://www.ncbi.nlm.nih.gov/pubmed/22879832 http://dx.doi.org/10.5812/hepatmon.6135

Ejemplares similares

COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
por: Bhoori, Sherrie, et al.
Publicado: (2020)

Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues
por: Maspero, Marianna, et al.
Publicado: (2023)

Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report
por: Knapstein, Johanna, et al.
Publicado: (2014)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses
por: Rognoni, Carla, et al.
Publicado: (2016)

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report
por: Covini, Giovanni, et al.
Publicado: (2018)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
por: Wagoner, Jessica, et al.
Publicado: (2011)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Wound Healing Activity of Silibinin in Mice
por: Samanta, Rojalini, et al.
Publicado: (2016)

Silibinin: an old drug for hematological disorders
por: Zou, Hai, et al.
Publicado: (2017)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
por: Sun, Kyung-Hoon, et al.
Publicado: (2023)

Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2019)

Effects of silibinin on hepatic warm ischemia-reperfusion injury in the rat model
por: Akbari-Kordkheyli, Vahid, et al.
Publicado: (2019)

Molecular genotyping to differentiate endogenous reactivation and exogenous reinfection of recurrent tuberculosis
por: Suzana, Shirly, et al.
Publicado: (2018)

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
por: Li Volti, Giovanni, et al.
Publicado: (2011)

Silibinin Effect on Methotrexate-Induced Hepatotoxicity in Rats
por: Yanaşoğlu, Emine, et al.
Publicado: (2022)

Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
por: Sasaki, Reina, et al.
Publicado: (2016)

Thrombosis after liver transplantation for hepatocellular carcinoma
por: Martinelli, Ida, et al.
Publicado: (2017)

Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity
por: Cheroni, Cristina, et al.
Publicado: (2015)

Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
por: Aghemo, Alessio, et al.
Publicado: (2013)

Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C
por: De Nicola, Stella, et al.
Publicado: (2014)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis
por: Rognoni, Carla, et al.
Publicado: (2018)

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B
por: Lv, Duo-Duo, et al.
Publicado: (2021)

Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
por: Verdura, Sara, et al.
Publicado: (2022)

Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit
por: Colli, Agostino, et al.
Publicado: (2016)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
por: Degasperi, Elisabetta, et al.
Publicado: (2014)

Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
por: Solitano, Virginia, et al.
Publicado: (2021)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
por: Spada, Francesca, et al.
Publicado: (2021)

Synergistic Antibacterial Effect between Silibinin and Antibiotics in Oral Bacteria
por: Lee, Young-Soo, et al.
Publicado: (2012)

Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes
por: Barbagallo, Ignazio, et al.
Publicado: (2016)

In Vitro Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
por: Rakelly de Oliveira, Dayanne, et al.
Publicado: (2015)

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
por: Hou, Xiaoying, et al.
Publicado: (2018)

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
por: Molavi, Ommoleila, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ibs6tlekhmghob0orgdqu6g4ef